BM 567 206ROTAC PD-1/PD-L1 degrader-1 When SCD inhibition has been

When SCD inhibition has been measured by desaturation index in tissues of rodents treated with MK-8245

Forsythoside B shows a significant recovery in myocardial function with improvement of LVSP and +/-dp/dt(max)

3 μM for PTP1B and TCPTP (T-cell protein tyrosine phosphatase)

20(7):1622

BM 567 206ROTAC PD-1/PD-L1 degrader-1 When SCD inhibition has beenIC50: 1. 1 nM for TXA2 receptor antagonism BM 567 is acting as an inhibitor of thromboxane A2 (TXA2) synthase and an antagonist of the TP receptor. Thromboxane A2 (TXA2), a potent thrombogenic and vasoconstrictor eicosanoid, is produced in large quantities by activated platelets. TXA2 has been reported as a causal factor in the onset of stroke and myocardial infarction. In vitro: BM 567 was identified as a dual acting antithrombogenic agent, acting as